BAT modulators (Discovery BioMed/Virginia Commonwealth University)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameBAT modulators (Discovery BioMed/Virginia Commonwealth University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase 2 modulators
TargetsTyrosine-protein kinase 2
Therapy Area/IndicationsObesityDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDiscovery BioMed Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDiscovery BioMed IncVirginia Commonwealth University
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A